Large-scale testing (Phase 3)Ended earlyNCT00447642
What this trial is testing
Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty
Who this might be right for
Corneal TransplantationCorneal Graft Rejection
Lux Biosciences, Inc. 122